Literature DB >> 26163823

ERK1/2 can feedback-regulate cellular MEK1/2 levels.

Seung-Keun Hong1, Pui-Kei Wu1, Mansi Karkhanis1, Jong-In Park2.   

Abstract

Signal transduction of the Raf/MEK/ERK pathway is regulated by various feedback mechanisms. Given the greater molar ratio between Raf-MEK than between MEK-ERK in cells, it may be possible that MEK1/2 levels are regulated to modulate Raf/MEK/ERK activity upon pathway stimulation. Nevertheless, it has not been reported whether MEK1/2 expression can be subject to a feedback regulation. Here, we report that the Raf/MEK/ERK pathway can feedback-regulate cellular MEK1 and MEK2 levels. In different cell types, ΔRaf-1:ER- or B-Raf(V600E)-mediated MEK/ERK activation increased MEK1 but decreased MEK2 levels. These regulations were abrogated by ERK1/2 knockdown mediated by RNA interference, suggesting the presence of a feedback mechanism that regulates MEK1/2 levels. Subsequently, analyses using qPCR and luciferase reporters of the DNA promoter and 3' untranslated region revealed that the feedback MEK1 upregulation was in part attributed to increased transcription. However, the feedback MEK2 downregulation was only observed at protein levels, which was blocked by the proteasome inhibitors, MG132 and bortezomib, suggesting that the MEK2 regulation is mediated at a post-translational level. These results suggest that the Raf/MEK/ERK pathway can feedback-regulate cellular levels of MEK1 and MEK2, wherein MEK1 levels are upregulated at transcriptional level whereas MEK2 levels are downregulated at posttranslational level.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ERK1/2; Feedback regulation; MEK1; MEK2; Raf

Mesh:

Substances:

Year:  2015        PMID: 26163823      PMCID: PMC4540659          DOI: 10.1016/j.cellsig.2015.07.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  42 in total

Review 1.  ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence.

Authors:  Sebastien Cagnol; Jean-Claude Chambard
Journal:  FEBS J       Date:  2009-10-16       Impact factor: 5.542

2.  Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells.

Authors:  X Wu; S J Noh; G Zhou; J E Dixon; K L Guan
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

3.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  The ERK Cascade: Distinct Functions within Various Subcellular Organelles.

Authors:  Inbal Wortzel; Rony Seger
Journal:  Genes Cancer       Date:  2011-03

5.  Post-transcriptional regulation of MEK-1 by polyamines through the RNA-binding protein HuR modulating intestinal epithelial apoptosis.

Authors:  Peng-Yuan Wang; Jaladanki N Rao; Tongtong Zou; Lan Liu; Lan Xiao; Ting-Xi Yu; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Biochem J       Date:  2010-02-24       Impact factor: 3.857

6.  AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.

Authors:  Seung-Keun Hong; Joseph H Jeong; Andrew M Chan; Jong-In Park
Journal:  Exp Cell Res       Date:  2013-05-20       Impact factor: 3.905

7.  Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1).

Authors:  A Brunet; G Pagès; J Pouysségur
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

8.  Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin.

Authors:  D F Lazar; R J Wiese; M J Brady; C C Mastick; S B Waters; K Yamauchi; J E Pessin; P Cuatrecasas; A R Saltiel
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

Review 9.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

10.  Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.

Authors:  Laure Voisin; Catherine Julien; Stéphanie Duhamel; Kailesh Gopalbhai; Isabelle Claveau; Marc K Saba-El-Leil; Ian Gaël Rodrigue-Gervais; Louis Gaboury; Daniel Lamarre; Mark Basik; Sylvain Meloche
Journal:  BMC Cancer       Date:  2008-11-17       Impact factor: 4.430

View more
  9 in total

Review 1.  Targeting ERK beyond the boundaries of the kinase active site in melanoma.

Authors:  Rachel M Sammons; Ranajeet Ghose; Kenneth Y Tsai; Kevin N Dalby
Journal:  Mol Carcinog       Date:  2019-06-12       Impact factor: 4.784

2.  Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in KRAS and BRAF Tumor Cells.

Authors:  Pui-Kei Wu; Seung-Keun Hong; Jong-In Park
Journal:  Mol Cell Biol       Date:  2017-08-28       Impact factor: 4.272

3.  A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses.

Authors:  Seung-Keun Hong; Pui-Kei Wu; Jong-In Park
Journal:  Cell Signal       Date:  2017-10-03       Impact factor: 4.315

4.  The road to ERK activation: Do neurons take alternate routes?

Authors:  Nadiatou Miningou; Kim T Blackwell
Journal:  Cell Signal       Date:  2020-01-13       Impact factor: 4.315

5.  Regulation of BRAF protein stability by a negative feedback loop involving the MEK-ERK pathway but not the FBXW7 tumour suppressor.

Authors:  Maria Aguilar Hernandez; Bipin Patel; Fiona Hey; Susan Giblett; Hayley Davis; Catrin Pritchard
Journal:  Cell Signal       Date:  2016-02-17       Impact factor: 4.315

6.  Transcriptional Response of White Adipose Tissue to Withdrawal of Vitamin B3.

Authors:  Wenbiao Shi; Maria A Hegeman; Atanaska Doncheva; Inge van der Stelt; Melissa Bekkenkamp-Grovenstein; Evert M van Schothorst; Charles Brenner; Vincent C J de Boer; Jaap Keijer
Journal:  Mol Nutr Food Res       Date:  2019-04-16       Impact factor: 5.914

Review 7.  MEK inhibitors for the treatment of non-small cell lung cancer.

Authors:  Jing Han; Yang Liu; Sen Yang; Xuan Wu; Hongle Li; Qiming Wang
Journal:  J Hematol Oncol       Date:  2021-01-05       Impact factor: 17.388

Review 8.  Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway.

Authors:  Pui-Kei Wu; Andrew Becker; Jong-In Park
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

9.  Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly.

Authors:  Siaw Shi Boon; Zigui Chen; Jintao Li; Karen Y C Lee; Liuyang Cai; Rugang Zhong; Paul K S Chan
Journal:  BMC Cancer       Date:  2019-12-12       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.